Luluca Capsule 75 mg (Pregabalin)

Adult dose

This medication is taken orally in two divided doses regardless of food intake. 1. Neuropathic Pain - Peripheral Neuropathic Pain The starting dose can be 150 mg per day, with a possible increase to 300 mg daily after 3 to 7 days. If necessary, the dose may be increased to a maximum of 600 mg per day at intervals of 7 days. - Central Neuropathic Pain The starting dose is 150 mg per day,

Child dose

The safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 are insufficient; therefore, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so patients should be carefully monitored for depression, mood changes, and unusual behaviors during treatment. Patients with allergies to any components of this medication or certain genetic lactose intolerance disorders should not take this medication. Diabetic patients should be cautious of weight gain and changes in blood sugar levels, and may need adjustments to their blood sugar control medications. If hypersensitivity reactions such as angioedema occur, stop taking the medication immediately and consult a healthcare professional. Older adults may experience symptoms such as dizziness, drowsiness, and loss of consciousness, so special caution is advised at the start of treatment. Some patients may experience blurred vision or changes in vision; if symptoms persist, consult a doctor. When discontinuing this medication, withdrawal symptoms such as insomnia, headaches, and anxiety may occur, so abrupt cessation should be avoided. Patients with a history of drug abuse should be evaluated carefully for the potential misuse and dependence on this medication. Patients with impaired renal function may require dose adjustments. Patients with heart disease should be cautious about symptoms of heart failure when taking this medication. The risk of drowsiness or respiratory depression may be increased when taken with other central nervous system depressants or alcohol, so caution is advised. Pregnant women should avoid taking this medication, especially in the early stages of pregnancy, due to the risk of fetal malformation, and women of childbearing age should use effective contraception. Lactating women should consider stopping breastfeeding or discontinuing the medication, as it may transfer into breast milk and affect the infant. Be cautious of the risk of accidents due to dizziness or drowsiness when driving or operating machinery after taking this medication. In cases of overdose, confusion, drowsiness, depression, seizures, etc., may occur, and immediate medical attention should be sought. This medication should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (including angioedema, facial swelling, swelling around the mouth and upper airway), chest tightness, difficulty breathing, cold sweats, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis), shortness of breath or difficulty breathing, asthma attacks, cough accompanied by respiratory abnormalities with fever, yellowing of skin or eyes,

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbances in orientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 15 and 30 degrees Celsius.

Appearance

A hard capsule with a brown-red upper part and a white lower part, containing a white to light yellow powder.

Package unit

30 capsules/bottle